Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

JAMA on java

This article was originally published in The Tan Sheet

Executive Summary

"Habitual" coffee consumption does not lead to an increased risk of hypertension in women, but the condition may be linked to regular soda intake, a prospective cohort study published in the Nov. 9 Journal of the American Medical Association finds. Wolfgang Winkelmayer, MD, Brigham & Women's Hospital, Boston, et al., analyzed data from the Nurses' Health Studies I and II to determine whether a link existed between consumption of caffeinated drinks and hypertension. The data covered 155,594 women "free from physician-diagnosed hypertension," who were followed for 12 years. The authors evaluated caffeine intake recorded on regularly administered questionnaires, finding that both sugared and diet colas were linked to hypertension. The results for consumption of caffeinated tea were "inconclusive"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098828

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel